SuperworthKorsana Biosciences market cap KRSA
Share price times shares outstanding: what the whole company sells for, since 2019.
- Today, Oct 23, 2026
- $20.9M
- Highest close in our data
- $415.1M
- May 2019
Korsana Biosciences is worth $20.9M at the close on Oct 23, 2026, at $31.31 a share.
That is up 196% over the last year and down 81% over five years.
Its highest close in our data was $415.1M in May 2019.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $20.9M | $4.3M | $26.6M | +295% |
| 2025 | $5.3M | $5.3M | $11.7M | −41% |
| 2024 | $8.9M | $3.9M | $10.5M | +9% |
| 2023 | $8.2M | $5M | $34.5M | −71% |
| 2022 | $28.5M | $16.5M | $65.4M | −62% |
| 2021 | $74.5M | $74.2M | $151.1M | −28% |
| 2020 | $103.9M | $67.6M | $284.6M | +49% |
| 2019 | $69.8M | $49.4M | $415.1M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Korsana Biosciences' size, closest first, today.
| Company | Market cap |
|---|---|
| KRSAKorsana Biosciences | $20.9M |
| ATNMActinium Pharmaceuticals | $47.8M |
| SPROSpero Therapeutics | $64.6M |
| LFVNLifevantage | $73.4M |
| Peer median | $64.6M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Korsana Biosciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.